bpc-157 fda not approved warning Peptides like and TB-500 are blowing up online for injury recovery, but they’re FDA-approved and they’re in a legal gray area. The end of July, an advisory committee meets to weigh in FDA takes coser look at
Description
The compound supports recovery at the cellular level by maintaining NAD+ levels, but it cannot overcome chronic overtraining or sleep deprivation
However, more clinical evidence is required to validate PRP's efficacy in nerve renewal and operational restoration in sciatic nerve injuries
The 2 of 12 patients who had 80% improvement after one intravesical treatment of 10 mg BPC-157 are requesting another injection, for which they have been scheduled
We anticipate that they will become public in the near future
